Sinopharm
1099.HK
#1870
Rank
S$11.67 B
Marketcap
$3.74
Share price
-0.23%
Change (1 day)
16.53%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : S$14.14 Billion

According to Sinopharm's latest financial reports the company's total debt is S$14.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31S$18.37 B26.65%
2021-12-31S$14.50 B4.35%
2020-12-31S$13.89 B30.62%
2019-12-31S$10.64 B-2.79%
2018-12-31S$10.94 B42.96%
2017-12-31S$7.65 B9.67%
2016-12-31S$6.98 B10.45%
2015-12-31S$6.32 B0.57%
2014-12-31S$6.28 B19.42%
2013-12-31S$5.26 B66.27%
2012-12-31S$3.16 B10.93%
2011-12-31S$2.85 B326.45%
2010-12-31S$0.66 B89.43%
2009-12-31S$0.35 B2.99%
2008-12-31S$0.34 B-25.04%
2007-12-31S$0.45 B23.76%
2006-12-31S$0.36 B